New to Meducation?
Sign up
Already signed up? Log In

Category

Preview
5
41

Psoriasis: assessment and management | Guidance and guidelines | NICE

Following the recent surveillance review which checks the need to update CG153, this guideline should not be updated at this time. This guideline will be checked again for update at its scheduled time point according to the methods described here.  
nice.org.uk
over 5 years ago
Preview
0
19

FDA OKs Topical Drug Combo (Enstilar) for Plaque Psoriasis

Enstilar combines calcipotriene and betamethasone dipropionate in a foam formulation for topical treatment of plaque psoriasis in adults.  
medscape.com
over 5 years ago
Preview
0
21

Hip Surgery Safe, Effective in Psoriatic Arthritis

Outcomes after hip replacement surgery are as good in patients with psoriatic arthritis or cutaneous psoriasis as in patients with OA; surgeons should not avoid offering replacement surgery as needed.  
medscape.com
over 5 years ago
Preview
0
14

Apremilast for Psoriasis and Psoriatic Arthritis

An overview of the use, safety, and efficacy of the PDE4 inhibitor apremilast, a promising new systemic therapy for treating psoriatic disease.  
medscape.com
over 5 years ago
Preview
0
7

Psoriasis Severity Tied to Vascular Inflammation

Plaque severity increases neutrophil levels and aortic vascular inflammation.  
medscape.com
over 5 years ago
Preview
0
13

Oral fumaric acid esters for the treatment of psoriasis | Cochrane

Psoriasis is a long-term inflammatory skin condition that can markedly reduce the quality of life of affected individuals. Treatments taken by mouth (oral treatments), such as methotrexate, ciclosporin, and acitretin, are commonly prescribed to people with moderate to severe psoriasis. Oral fumaric acid esters (FAE) are licensed for the treatment of psoriasis in Germany but remain unlicensed in most other countries. This means that there are different treatment options offered to people in different countries.  
cochrane.org
over 5 years ago